Assessment of neurologists’ knowledge regarding intravenous fibrinolytic therapy for acute stroke in Shanxi province in China
نویسندگان
چکیده
BACKGROUND Limitations in physicians' knowledge regarding fibrinolytic therapy for acute ischemic stroke may contribute to low rate of fibrinolytic therapy in China. Here physicians' knowledge was surveyed on intravenous fibrinolytic therapy for acute ischemic stroke. METHODS Neurologists (n = 175) from 27 major general hospitals in Shanxi province, P. R. China, were invited to complete questionnaires regarding their basic knowledge of intravenous fibrinolytic therapy for acute ischemic stroke. The questionnaire contained 12 multiple-choice questions. One point was assigned for a correct answer and zero point for a false or unanswered question. RESULTS One hundred and thirty-one neurologists (74.9%) responded to the questionnaires. The mean accuracy rate of 12 questions was 54.9 ± 25.01% (range 0.8-96.2%). The mean total score for respondents was 6.59 ± 2.03 (range 2-11). More years of experience and higher academic degrees were independent factors related to the total scores (P = 0.000 and P = 0.004, respectively). CONCLUSIONS The neurologists in this study were knowledge deficient in the area of intravenous fibrinolytic therapy for acute ischemic stroke. This partially accounts for the low rate of fibrinolytic therapy in China.
منابع مشابه
Chinese neurologists’ perspective on intravenous thrombolysis for acute ischemic stroke
Objectives This study examined the neurologists' perspective toward intravenous thrombolysis for the treatment of acute ischemic stroke and the influencing factors in a Chinese Province. Methods A cross-sectional study was conducted from 1 October 2014 to 31 January 2015. A total of 719 neurologists from 66 hospitals in Hubei Province were included. A questionnaire was designed, and multivari...
متن کاملCommunity use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey.
BACKGROUND AND PURPOSE Little is known of neurologists' viewpoints regarding intravenous tPA use or institutional readiness to evaluate potential thrombolytic candidates. METHODS Surveys were distributed at the Brain Matters Stroke Management Workshops held in 16 cities in the United States. RESULTS Intravenous tPA was administered by 46.9% of responding neurologists. Almost 30% (29.9%) of ...
متن کاملSafety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
Background: Thrombolytic therapy is the only approved treatment for acute cerebral ischemia. The hemorrhagic transformation is the greatest complication of this treatment, which may occur after recanalization of occluded artery. The aim of this study was to determine factors associated with clinical improvement and worsening in patients with acute ischemic stroke treated with intravenous th...
متن کاملPrimary prostate solitary neurofibroma without neurofibromatosis-I: a case report and narrative review of the literature
Neurofibroma of the prostate is an extremely rare benign tumor, particularly when it is not associated with neurofibromatosis-I (NF-1). This study aimed to report the case of a 44-year-old man who presented with dysuria for about 4 years. Magnetic resonance imaging (MRI) showed a mass in the prostate with “target sign” on T2-weighted imaging. The mass was surgically excised, and histopathologic...
متن کاملUse of intravenous heparin by North American neurologists: do the data matter?
BACKGROUND AND PURPOSE Our aim was to determine current usage patterns of intravenous heparin for patients with acute ischemic stroke. METHODS A survey was undertaken of 280 neurologists from the United States and 270 neurologists from Canada. Brief vignettes were presented for the following 5 scenarios: stroke in evolution, atrial fibrillation-related stroke (A FIB), vertebrobasilar stroke, ...
متن کامل